Mannkind reported $18.27M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adma Biologics ADMA:US USD 162.91M 16.84M
Dynavax Technologies DVAX:US USD 102.61M 28.63M
Eli Lilly And LLY:US USD 3.83B 68.3M
Halozyme Therapeutics HALO:US USD 103.28M 5.66M
Insmed INSM:US USD 66.28M 741K
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Macrogenics MGNX:US USD 1.09M 1.86M
Mannkind MNKD:US USD 18.27M 2.3M
Novavax NVAX:US USD 82.43M 173.87M
Peregrine Pharmaceuticals PPHM:US USD 39.06M 8.71M